This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
severe covid | 138 |
linked oligosaccharides | 107 |
amino acid | 105 |
cell responses | 98 |
fc ab | 96 |
trigger factor | 87 |
reading frame | 86 |
vaccinia virus | 78 |
receptor activity | 75 |
sperm receptor | 75 |
spike protein | 74 |
infected cells | 64 |
respiratory syndrome | 63 |
immune response | 59 |
acute respiratory | 56 |
gene expression | 56 |
viral rna | 56 |
amino acids | 52 |
cell surface | 51 |
classical monocytes | 49 |
rna polymerase | 49 |
experimental procedures | 49 |
zonae pellucidae | 47 |
severe acute | 46 |
type i | 46 |
membrane proteins | 45 |
portal vertex | 43 |
previously described | 43 |
cord uid | 43 |
cell doi | 43 |
doc id | 43 |
syndrome coronavirus | 43 |
cd low | 43 |
plasma membrane | 42 |
membrane insertion | 41 |
endoplasmic reticulum | 41 |
united states | 39 |
herpes simplex | 39 |
specific cd | 39 |
simplex virus | 39 |
nucleotide sequence | 39 |
severe patients | 39 |
cancer patients | 38 |
early career | 38 |
molecular weight | 38 |
heparan sulfate | 38 |
mild covid | 37 |
membrane protein | 37 |
monoclonal antibodies | 35 |
influenza virus | 35 |
frameshift site | 35 |
acid residues | 35 |
penton vertex | 35 |
immune responses | 34 |
severe disease | 34 |
vertex sub | 33 |
innate immune | 33 |
reading frames | 33 |
rna viruses | 33 |
viral proteins | 32 |
binding site | 32 |
low cd | 32 |
cdna clones | 32 |
coronavirus disease | 32 |
flow cytometry | 32 |
reverse transcriptase | 31 |
neutralizing antibodies | 31 |
ribosomal frameshifting | 30 |
signal sequence | 30 |
golgi complex | 30 |
initiation codon | 30 |
mg ml | 30 |
stop codon | 30 |
electron microscopy | 30 |
performed using | 29 |
measles virus | 29 |
chromosome fragment | 29 |
room temperature | 29 |
novel coronavirus | 29 |
peripheral blood | 28 |
golgi apparatus | 28 |
receptor binding | 28 |
hsvl glycoproteins | 27 |
zona pellucida | 27 |
cell lines | 27 |
class i | 27 |
signal peptidase | 26 |
cell response | 26 |
epithelial cells | 26 |
viral infection | 26 |
virus entry | 26 |
structural basis | 25 |
dicentric chromosome | 25 |
binding domain | 25 |
blood samples | 24 |
cd high | 24 |
open reading | 24 |
distilled water | 23 |
nervous system | 23 |
cell cycle | 23 |
viral genome | 23 |
mm tris | 23 |
antibody responses | 23 |
east respiratory | 22 |
mild alkaline | 22 |
virus genome | 22 |
membrane vesicles | 22 |
middle east | 22 |
high levels | 22 |
rna sequencing | 22 |
type ii | 22 |
virus particles | 22 |
disease severity | 21 |
protein synthesis | 21 |
viral rnas | 21 |
immune cells | 21 |
thermo fisher | 21 |
whole blood | 21 |
immunodeficiency virus | 21 |
secondary structure | 21 |
infected cell | 21 |
electrophoretic mobilities | 21 |
career faculty | 21 |
leader sequence | 21 |
see experimental | 21 |
cen dna | 21 |
virus type | 21 |
fusion proteins | 21 |
sars coronavirus | 20 |
coding region | 20 |
coding sequences | 19 |
membrane assembly | 19 |
host cell | 19 |
new york | 19 |
social media | 19 |
i interferon | 19 |
monoclonal antibody | 19 |
rna transcripts | 19 |
class ii | 19 |
mass cytometry | 19 |
translational pause | 19 |
primer extension | 19 |
unpublished data | 19 |
lung injury | 19 |
cd cd | 19 |
fusion protein | 19 |
translation initiation | 19 |
mild disease | 18 |
convalescent individuals | 18 |
cell types | 18 |
em structure | 18 |
cell type | 18 |
vitro translation | 18 |
lead contact | 18 |
unexposed donors | 18 |
cell line | 18 |
immature forms | 18 |
cdna clone | 18 |
mg kg | 18 |
human immunodeficiency | 18 |
immune cell | 18 |
cell entry | 18 |
viral replication | 17 |
respiratory tract | 17 |
respiratory distress | 17 |
signal recognition | 17 |
virus replication | 17 |
immature neutrophils | 17 |
vesicular stomatitis | 17 |
plasma level | 17 |
egg zonae | 17 |
human cells | 16 |
membrane fusion | 16 |
viral infections | 16 |
shelled particles | 16 |
recognition particle | 16 |
fisher scientific | 16 |
fatty acid | 16 |
gel filtration | 16 |
ty elements | 16 |
leukemia virus | 16 |
hla class | 16 |
sialic acid | 16 |
stranded rna | 16 |
family members | 16 |
human ace | 16 |
may also | 16 |
late rna | 16 |
penton vertices | 16 |
leader rna | 16 |
stomatitis virus | 15 |
nucleic acid | 15 |
pdb id | 15 |
fold symmetry | 15 |
tissue culture | 15 |
cellular mrnas | 15 |
single cell | 15 |
rna virus | 15 |
electrophoretic mobility | 15 |
viral glycoproteins | 15 |
hospitalized patients | 15 |
viral entry | 15 |
total rna | 15 |
cells infected | 15 |
career researchers | 15 |
start site | 15 |
dr low | 15 |
ace binding | 15 |
emergency myelopoiesis | 15 |
viral protein | 15 |
galnac oligosaccharidase | 15 |
covid crisis | 15 |
mm edta | 15 |
difference map | 15 |
frameshift event | 15 |
human coronavirus | 15 |
termination codon | 14 |
dna polymerase | 14 |
binding sites | 14 |
immune dysregulation | 14 |
vero cells | 14 |
high level | 14 |
ribosomal rna | 14 |
cd cells | 14 |
marker genes | 14 |
total number | 14 |
public health | 14 |
elution profile | 14 |
acid sequence | 14 |
charged amino | 14 |
spike glycoprotein | 14 |
vp spike | 14 |
virus infection | 14 |
transport vesicles | 14 |
human igg | 14 |
nuclease sl | 14 |
viral mrna | 14 |
structural proteins | 14 |
two different | 14 |
respiratory failure | 13 |
classical monocyte | 13 |
cleavage site | 13 |
cuu codon | 13 |
dna fragment | 13 |
nsp binds | 13 |
rna molecules | 13 |
coated vesicles | 13 |
cytoplasmic domain | 13 |
distress syndrome | 13 |
secretory proteins | 13 |
immune system | 13 |
rna hybrids | 13 |
interferon response | 13 |
medium containing | 13 |
amino terminus | 13 |
calprotectin plasma | 13 |
see also | 13 |
vp shell | 13 |
co i | 13 |
dna fragments | 13 |
virus late | 13 |
alkaline hydrolysis | 13 |
derived suppressor | 13 |
subacute sclerosing | 13 |
remains unclear | 13 |
nucleotide frameshift | 13 |
mrna splicing | 13 |
polypeptide chain | 13 |
cdna cloning | 13 |
er membrane | 12 |
dendritic cells | 12 |
viral load | 12 |
hepatitis virus | 12 |
mouse hepatitis | 12 |
ctf protein | 12 |
well plates | 12 |
sperm binding | 12 |
cell rna | 12 |
virus rna | 12 |
taaat motif | 12 |
neutralizing antibody | 12 |
determine whether | 12 |
graduate students | 12 |
binding proteins | 12 |
spectral flow | 12 |
cd expression | 12 |
pseudoknot structure | 12 |
dependent rna | 12 |
reticulocyte lysate | 12 |
helix bundle | 12 |
infectious virus | 12 |
sl mapping | 12 |
protective immunity | 12 |
ace expression | 12 |
memory cd | 12 |
pseudotyped virus | 12 |
viral envelope | 12 |
infected patients | 12 |
linked oligosaccharide | 12 |
late gene | 12 |
highly conserved | 12 |
dna sequence | 12 |
neurological manifestations | 12 |
data suggest | 12 |
funding agencies | 12 |
protein binding | 12 |
alkaline borohydride | 12 |
polyacrylamide gels | 12 |
outer shell | 12 |
symptom onset | 12 |
mature forms | 12 |
reverse genetics | 12 |
void volume | 12 |
described previously | 12 |
myeloid cells | 12 |
important role | 11 |
importation risk | 11 |
pseudotyped viruses | 11 |
expressed genes | 11 |
bound egg | 11 |
rbd region | 11 |
acid sequences | 11 |
high expression | 11 |
plasma levels | 11 |
human monoclonal | 11 |
cytoplasmic side | 11 |
sequence analysis | 11 |
rna transcription | 11 |
neutrophil clusters | 11 |
termination codons | 11 |
virion production | 11 |
head domain | 11 |
intensive care | 11 |
egg zp | 11 |
myeloid cell | 11 |
enveloped viruses | 11 |
signal sequences | 11 |
reporter plasmid | 11 |
messenger rna | 11 |
free system | 11 |
structural analysis | 11 |
clinical course | 11 |
newly synthesized | 11 |
group i | 11 |
simian virus | 11 |
murine leukemia | 11 |
mm naoh | 11 |
binding protein | 11 |
low levels | 11 |
cell culture | 11 |
monocyte fraction | 11 |
sequences upstream | 11 |
rna synthesis | 11 |
viral genomes | 11 |
igg ab | 11 |
rich region | 11 |
gel electrophoresis | 11 |
cell subsets | 11 |
neutralizing mabs | 11 |
antiviral response | 11 |
sl start | 11 |
sperm bound | 11 |
aug codon | 11 |
rabbit reticulocyte | 11 |
will also | 11 |
sclerosing panencephalitis | 11 |
hi cd | 11 |
significantly higher | 11 |
cell populations | 11 |
dr lo | 11 |
cd monocytes | 11 |
leader rnas | 11 |
vitro competition | 10 |
virus gene | 10 |
cd neutrophils | 10 |
virus glycoproteins | 10 |
foamy viruses | 10 |
gustave roussy | 10 |
mrna translation | 10 |
mosaic virus | 10 |
positively charged | 10 |
vaccine development | 10 |
acute moderate | 10 |
mm nacl | 10 |
apparent molecular | 10 |
associated herpesvirus | 10 |
terminal end | 10 |
spanning region | 10 |
animal models | 10 |
san diego | 10 |
control patients | 10 |
personal communication | 10 |
coronavirus infection | 10 |
travel restrictions | 10 |
seq data | 10 |
host cells | 10 |
expression levels | 10 |
convalescent sera | 10 |
clinical characteristics | 10 |
pellucida glycoproteins | 10 |
human coronaviruses | 10 |
nucleotide sequences | 10 |
disease control | 10 |
rough endoplasmic | 10 |
catc binding | 10 |
capsid protein | 10 |
cohort study | 10 |
sendai virus | 10 |
mammalian expression | 10 |
zp oligosaccharides | 10 |
fragment containing | 10 |
purified zp | 10 |
disease virus | 10 |
transcription initiation | 10 |
genomic rna | 10 |
coronavirus spike | 10 |
i membrane | 10 |
molecular mechanisms | 10 |
potent neutralizing | 10 |
agg codon | 10 |
academic science | 10 |
glycosylation sites | 10 |
cleavable signal | 10 |
viral mrnas | 10 |
new england | 10 |
per cell | 10 |
saccharomyces cerevisiae | 10 |
patients infected | 10 |
might also | 10 |
cap selection | 10 |
low expression | 10 |
data indicate | 10 |
expression vectors | 10 |
catc occupancy | 10 |
final concentration | 10 |
triplex ta | 10 |
convalescent phase | 10 |
clinical features | 10 |
mature neutrophils | 10 |
see table | 10 |
vp spikes | 10 |
generated using | 10 |
culture medium | 10 |
kinetochore mutants | 10 |
cap structure | 10 |
golgi transport | 10 |
nuclear export | 10 |
defocus value | 10 |
dna replication | 10 |
star methods | 9 |
gene product | 9 |
hereby marked | 9 |
thymidine kinase | 9 |
radiolabeled oligosaccharides | 9 |
live virus | 9 |
bone marrow | 9 |
membrane traffic | 9 |
nsp binding | 9 |
mm hepes | 9 |
dr hi | 9 |
second codon | 9 |
igg fc | 9 |
ng ml | 9 |
spanning segment | 9 |
viral titer | 9 |
intact cells | 9 |
strongly suggest | 9 |
must therefore | 9 |
cell membrane | 9 |
stimulation index | 9 |
article must | 9 |
monocyte subset | 9 |
trna genes | 9 |
viral dna | 9 |
accessory proteins | 9 |
golgi stack | 9 |
may allow | 9 |
lab closures | 9 |
high cd | 9 |
national institutes | 9 |
predicted amino | 9 |
protein expression | 9 |
vitro transcription | 9 |
acid changes | 9 |
two independent | 9 |
protein production | 9 |
viral gene | 9 |
crystal structure | 9 |
caveolar raft | 9 |
nucleic acids | 9 |
blood cell | 9 |
loop structure | 9 |
social distancing | 9 |
attachment factors | 9 |
persistent infections | 9 |
results obtained | 9 |
section solely | 9 |
risk factors | 9 |
transcription factor | 9 |
slippery sequence | 9 |
bovine serum | 9 |
wheat germ | 9 |
sequencing data | 9 |
two severe | 9 |
test dicentric | 9 |
viral infectivity | 9 |
cs cs | 9 |
invariant chain | 9 |
ab binding | 9 |
strand rna | 9 |
nasal washes | 9 |
gal promoter | 9 |
mu ml | 9 |
endothelial cells | 9 |
ii membrane | 9 |
postdoctoral fellows | 9 |
page charges | 9 |
recent studies | 9 |
lung tissue | 9 |
low classical | 9 |
membrane translocation | 9 |
envelope protein | 9 |
hours post | 9 |
animal cells | 9 |
sv infected | 9 |
aminobutyric acid | 9 |
hydrophobic segment | 9 |
bp fragment | 9 |
results demonstrate | 9 |
icosahedral reconstruction | 9 |
monocyte clusters | 9 |
critically ill | 9 |
septic shock | 9 |
terminal domain | 9 |
post infection | 8 |
mm naci | 8 |
new coronavirus | 8 |
staining buffer | 8 |
studies suggest | 8 |
terminal residues | 8 |
electron microscope | 8 |
cancer campus | 8 |
sectoring phenotype | 8 |
galactosidase activity | 8 |
neutrophils among | 8 |
roussy cancer | 8 |
human antibody | 8 |
subtomogram averaging | 8 |
sl analysis | 8 |
graphpad prism | 8 |
messenger rnas | 8 |
subgenomic rnas | 8 |
bamhl site | 8 |
lower porf | 8 |
protein complex | 8 |
medial golgi | 8 |
protein products | 8 |
tegument proteins | 8 |
late transcripts | 8 |
coat protein | 8 |
subtype strains | 8 |
linked glycosylation | 8 |
drs data | 8 |
passenger volumes | 8 |
nk cells | 8 |
conformational changes | 8 |
kshv virions | 8 |
niran domain | 8 |
read counts | 8 |
many viruses | 8 |
mediated endocytosis | 8 |
porf mutants | 8 |
mrna entry | 8 |
influenza viruses | 8 |
protein translocation | 8 |
length cdna | 8 |
converting enzyme | 8 |
secretory pathway | 8 |
frameshifting occurs | 8 |
late mrnas | 8 |
start codon | 8 |
negative control | 8 |
von heijne | 8 |
codons downstream | 8 |
negative strand | 8 |
cells expressing | 8 |
unexposed individuals | 8 |
nonpermissive temperature | 8 |
oligosaccharide chains | 8 |
trans splicing | 8 |
portal cap | 8 |
expression vector | 8 |
calculated using | 8 |
entry channel | 8 |
brain cells | 8 |
two codons | 8 |
envelope glycoprotein | 8 |
commonly used | 8 |
violin plots | 8 |
time points | 8 |
cat protein | 8 |
acz gene | 8 |
ebola virus | 8 |
results indicate | 8 |
acid change | 8 |
spearman correlation | 8 |
hela cells | 8 |
dr expression | 8 |
heat shock | 8 |
signaling pathways | 8 |
chromosome segregation | 8 |
portal dodecamer | 8 |
sindbis virus | 8 |
remains unknown | 8 |
direct rna | 8 |
standard deviation | 8 |
three classes | 8 |
reference strain | 8 |
hydrogen bonds | 8 |
made available | 8 |
antibody response | 8 |
shift site | 8 |
authentic sars | 8 |
marked advertisement | 8 |
sample collection | 8 |
umap analysis | 8 |
gene encoding | 8 |
foamy virus | 8 |
virion rna | 8 |
protein ectodomain | 8 |
putative kinetochore | 8 |
dna probe | 8 |
active site | 8 |
cell data | 8 |
leucine codons | 8 |
adaptive immune | 8 |
cloned dna | 8 |
mibe case | 8 |
previously reported | 8 |
monocyte subsets | 8 |
genomic dna | 8 |
protein elution | 8 |
size class | 8 |
gene ontology | 8 |
one rbd | 8 |
cell reactivity | 8 |
genetic recombination | 8 |
protein levels | 7 |
protein trafficking | 7 |
liquid nitrogen | 7 |
potent neutralization | 7 |
surface hs | 7 |
reduced binding | 7 |
follicular helper | 7 |
portal protein | 7 |
mechanical ventilation | 7 |
three codons | 7 |
golgi compartments | 7 |
blood cells | 7 |
lytic viruses | 7 |
porf head | 7 |
plasmid dna | 7 |
mild patient | 7 |
nanopore drs | 7 |
forward transport | 7 |
electron tomography | 7 |
vesicular transport | 7 |
translational inhibition | 7 |
bd rhapsody | 7 |
transcriptional readthrough | 7 |
sensitive mutants | 7 |
capsid vertices | 7 |
golgi cisternae | 7 |
attachment protein | 7 |
cluster expressed | 7 |
oligosaccharides released | 7 |
noncoding rnas | 7 |
rna structure | 7 |
may occur | 7 |
microsomal membranes | 7 |
exposed family | 7 |
cell fusion | 7 |
readthrough transcripts | 7 |
organ failure | 7 |
life cycle | 7 |
glycosylation mutants | 7 |
host immune | 7 |
three reading | 7 |
healthy individuals | 7 |
mm dtt | 7 |
essential gene | 7 |
days post | 7 |
kd protein | 7 |
two types | 7 |
ex vivo | 7 |
uga codon | 7 |
highly specific | 7 |
functional analysis | 7 |
dna sequencing | 7 |
informed consent | 7 |
neutrophil subsets | 7 |
mental status | 7 |
variable genes | 7 |
pixel size | 7 |
catc helix | 7 |
frameshift sites | 7 |
cl cells | 7 |
reported previously | 7 |
determined using | 7 |
capsid proteins | 7 |
genetic information | 7 |
genetic diversity | 7 |
total monocytes | 7 |
structural polypeptide | 7 |
lipid rafts | 7 |
cell epitopes | 7 |
also found | 7 |
immediately upstream | 7 |
purified proompa | 7 |
major histocompatibility | 7 |
adaptive immunity | 7 |
sum test | 7 |
higher levels | 7 |
suppressor cells | 7 |
translocation reaction | 7 |
polyacrylamide gel | 7 |
suppress global | 7 |
forest virus | 7 |
loaded onto | 7 |
nonstructural protein | 7 |
protein binds | 7 |
labeled dna | 7 |
healthy controls | 7 |
conformational change | 7 |
cells derived | 7 |
coding regions | 7 |
results suggest | 7 |
rnap ii | 7 |
newcastle disease | 7 |
release factor | 7 |
mhc class | 7 |
density maps | 7 |
recovered covid | 7 |
colony color | 7 |
local resolution | 7 |
cells using | 7 |
right panel | 7 |
dimensionality reduction | 7 |
molecular cloning | 7 |
serially diluted | 7 |
viral mirnas | 7 |
virus glycoprotein | 7 |
acute lung | 7 |
glycopeptides derived | 7 |
polymerase complexes | 7 |
intermediate compartment | 7 |
reporter gene | 7 |
mumps virus | 7 |
monocytes macrophages | 7 |
human brain | 7 |
temperature sensitivity | 7 |
also known | 7 |
cerevisiae kinetochore | 7 |
semliki forest | 7 |
protein interactions | 7 |
washed twice | 7 |
exoplasmic side | 7 |
primer elongation | 7 |
bronchial epithelial | 7 |
adapted sars | 7 |
cells ml | 7 |
ifn response | 7 |
protected fragments | 7 |
translocated promoter | 7 |
washington state | 7 |
presecretory proteins | 7 |
wilcoxon rank | 7 |
mild patients | 7 |
oral swabs | 7 |
heavy chain | 7 |
reverse transcription | 7 |
runoff transcripts | 7 |
region iv | 7 |
minimal sequence | 7 |
transcriptional block | 7 |
specific interactions | 7 |
germ cell | 7 |
severe cases | 7 |
also observed | 7 |
buffered saline | 7 |
length heterogeneity | 7 |
cell attachment | 7 |
acute phase | 7 |
therapeutic development | 7 |
rna modifications | 7 |
closely related | 7 |
discontinuous transcription | 7 |
cellular functions | 7 |
secretory protein | 7 |
structure determination | 7 |
coated pits | 7 |
lytic replication | 7 |
competition assay | 7 |
infectious cdna | 7 |
viruses use | 7 |
protease inhibitor | 7 |
ab bound | 7 |
structural features | 7 |
pre sequence | 7 |
globular domain | 7 |
translocation across | 7 |
splice site | 7 |
mitotic segregation | 6 |
glcnac transferase | 6 |
carrier vesicles | 6 |
cytopathic effect | 6 |
receptor ace | 6 |
late vaccinia | 6 |
consensus sequence | 6 |
nsp nsp | 6 |
gag gene | 6 |
human population | 6 |
requiring hospitalization | 6 |
neurological complications | 6 |
like particles | 6 |
statistical analyses | 6 |
sulfate proteoglycans | 6 |
dog pancreas | 6 |
binned tomograms | 6 |
golgi network | 6 |
genome segment | 6 |
like youtube | 6 |
early sars | 6 |
nucleotide substitutions | 6 |
nucleotide minimal | 6 |
per sample | 6 |
gfp reporter | 6 |
simian rotavirus | 6 |
cov antibody | 6 |
surface marker | 6 |
late endosomes | 6 |
human lung | 6 |
binding buffer | 6 |
vaccinia virions | 6 |
donated blood | 6 |
general population | 6 |
dendritic cell | 6 |
previous studies | 6 |
mitotic spindle | 6 |
international importation | 6 |
virus binding | 6 |
unique opportunity | 6 |
serial dilutions | 6 |
rna species | 6 |
neutrophils expressing | 6 |
inner shell | 6 |
dna packaging | 6 |
common nding | 6 |
leader sequences | 6 |
patients hospitalized | 6 |
outbreak science | 6 |
immediately downstream | 6 |
patient samples | 6 |
discontinuously synthesized | 6 |
standard fsc | 6 |
ecorl site | 6 |
herpesvirus capsid | 6 |
early rna | 6 |
nanopore direct | 6 |
ucsf chimera | 6 |
sarcoma virus | 6 |
uninfected cells | 6 |
spliced mrnas | 6 |
observations suggest | 6 |
large globular | 6 |
rna modification | 6 |
genome replication | 6 |
rna binding | 6 |
fli patients | 6 |
aim assays | 6 |
leader peptide | 6 |
data using | 6 |
image processing | 6 |
fully spliced | 6 |
coding sequence | 6 |
patients exhibited | 6 |
pneumonia outbreak | 6 |
rna recombination | 6 |
three times | 6 |
convalescent donors | 6 |
cell viability | 6 |
global mrna | 6 |
rbd domain | 6 |
disease pathogenesis | 6 |
infectious bronchitis | 6 |
lower respiratory | 6 |
mice lacking | 6 |
oligosaccharides derived | 6 |
matrix protein | 6 |
human bronchial | 6 |
extracellular traps | 6 |
library preparation | 6 |
viruses may | 6 |
soluble ace | 6 |
internal initiation | 6 |
intracellular transport | 6 |
patients compared | 6 |
electron cryomicroscopy | 6 |
fab fragments | 6 |
vaccinia late | 6 |
also detected | 6 |
molecular mass | 6 |
two additional | 6 |
kinetochore proteins | 6 |
fetal bovine | 6 |
posttranslational modifications | 6 |
significantly decreased | 6 |
thermofisher scientific | 6 |
phenotypic analysis | 6 |
carboxyl terminus | 6 |
modification sites | 6 |
bronchitis virus | 6 |
homologous recombination | 6 |
loop structures | 6 |
formate dehydrogenase | 6 |
viruses containing | 6 |
proteolytic cleavage | 6 |
preliminary data | 6 |
neutralization assay | 6 |
approximately nucleotides | 6 |
parainfluenza virus | 6 |
cov spike | 6 |
mv genomes | 6 |
cell activation | 6 |
western blotting | 6 |
protein transport | 6 |
enzymes involved | 6 |
mm sodium | 6 |
may provide | 6 |
hi monocytes | 6 |
severe respiratory | 6 |
vast majority | 6 |
acid binding | 6 |
neutrophil extracellular | 6 |
total cd | 6 |
mm imidazole | 6 |
plasmid pmb | 6 |
sites like | 6 |
kshv virion | 6 |
mammalian cells | 6 |
translation apparatus | 6 |
outbreak dynamics | 6 |
acceptor golgi | 6 |
unfractionated heparin | 6 |
essential cellular | 6 |
integral membrane | 6 |
coat proteins | 6 |
low ph | 6 |
human cd | 6 |
per virion | 6 |
lipid bilayer | 6 |
golgi compartment | 6 |
amino coterminal | 6 |
international airport | 6 |
viral particles | 6 |
leaky uag | 6 |
permissive temperature | 6 |
mononuclear cells | 6 |
buffer containing | 6 |
binding vertices | 6 |
rna segment | 6 |
ii channels | 6 |
secondary screens | 6 |
marker expression | 6 |
kshv lytic | 6 |
proteins encoded | 6 |
encoded proteins | 6 |
stop codons | 6 |
binding assay | 6 |
bat origin | 6 |
see star | 6 |
density gradient | 6 |
care unit | 6 |
released oligosaccharides | 6 |
nonstructural proteins | 6 |
statistically significant | 6 |
frameshift reporter | 6 |
rna genome | 6 |
marker gene | 6 |
cd hi | 6 |
differentially expressed | 6 |
avian influenza | 6 |
distinct compartments | 6 |
ill patients | 6 |
clinical data | 6 |
will provide | 6 |
prefusion conformation | 6 |
conserved taaat | 6 |
error bars | 6 |
coli rna | 6 |
protein sequence | 6 |
virus particle | 6 |
peptidase cleavage | 6 |
severe patient | 6 |
analyzed using | 6 |
copy number | 6 |
passenger volume | 6 |
ab epitope | 6 |
linked glycans | 6 |
target cells | 6 |
lower levels | 6 |
diversification leads | 6 |
also used | 6 |
type oligosaccharides | 6 |
covid patients | 6 |
aim cells | 6 |
derived probes | 6 |
viral rdrp | 6 |
golgi membranes | 6 |
incompletely spliced | 6 |
control samples | 6 |
kinetochore function | 6 |
immune protection | 6 |
common hla | 6 |
respiratory disease | 6 |
cd epitopes | 6 |
yeast ty | 6 |
globular density | 6 |
lung lobes | 6 |
unclear whether | 6 |
threonine residues | 6 |
flow cell | 6 |
pstl site | 6 |
methionine residues | 6 |
nanopore sequencing | 6 |
first strand | 6 |
may play | 5 |
lung viral | 5 |
associated tegument | 5 |
refined coordinates | 5 |
passenger proteins | 5 |
special uga | 5 |
oxidized phospholipids | 5 |
viral loads | 5 |
worth noting | 5 |
antibodies directed | 5 |
pathway analysis | 5 |
signal peptide | 5 |
membrane anchor | 5 |
sucrose gradient | 5 |
three cases | 5 |
cell lysates | 5 |
rbd protein | 5 |
vp may | 5 |
avian coronavirus | 5 |
domestic importation | 5 |
kinetochore mutant | 5 |
urgent need | 5 |
using relion | 5 |
chain variable | 5 |
exact number | 5 |
animal viruses | 5 |
infected vero | 5 |
canonical sgrnas | 5 |
cells carrying | 5 |
clusters identified | 5 |
embryo zonae | 5 |
expression plasmids | 5 |
samples used | 5 |
rous sarcoma | 5 |
remote learning | 5 |
kshv catc | 5 |
blood mononuclear | 5 |
overlapping peptides | 5 |
least one | 5 |
rna transcribed | 5 |
wild type | 5 |
transcriptase complex | 5 |
increased expression | 5 |
virus capsid | 5 |
cff strain | 5 |
upper respiratory | 5 |
ciliated cells | 5 |
two porf | 5 |
inflammatory cytokines | 5 |
ribosomal frameshift | 5 |
native spike | 5 |
dependent membrane | 5 |
recombinant proteins | 5 |
protein interacts | 5 |
moderate covid | 5 |
host mrna | 5 |
also bound | 5 |
icosahedral symmetry | 5 |
median eminence | 5 |
viral propagation | 5 |
molar ratio | 5 |
many different | 5 |
complex type | 5 |
fold decrease | 5 |
type sequence | 5 |
protein coding | 5 |
human cytomegalovirus | 5 |
affinity chromatography | 5 |
patient groups | 5 |
two nontemplated | 5 |
antibodies specific | 5 |
capsid assembly | 5 |
elution buffer | 5 |
campus gustave | 5 |
cystic fibrosis | 5 |
mock infected | 5 |
ectodomain protein | 5 |
analysis software | 5 |
human sars | 5 |
specific memory | 5 |
pseudovirus neutralization | 5 |
density map | 5 |
synthetic oligonucleotide | 5 |
classical cd | 5 |
late transcription | 5 |
glycosylation site | 5 |
four lanes | 5 |
kinase activity | 5 |
several viral | 5 |
cellular mirnas | 5 |
dimensional structure | 5 |
protein associated | 5 |
will need | 5 |
next generation | 5 |
sectoring phenotypes | 5 |
sequential localized | 5 |
analysis using | 5 |
healthy blood | 5 |
monocyte compartment | 5 |
brain tissue | 5 |
pal fusion | 5 |
may help | 5 |
secondary structures | 5 |
regions i | 5 |
cff mutants | 5 |
enveloped virus | 5 |
mammalian sperm | 5 |
new science | 5 |
noncoding rna | 5 |
spike proteins | 5 |
human fc | 5 |
primary structure | 5 |
applied biosystems | 5 |
viral transcripts | 5 |
nucleotides downstream | 5 |
storage buffer | 5 |
among total | 5 |
vp molecules | 5 |
late mrna | 5 |
unpublished observations | 5 |
upper porf | 5 |
induced motion | 5 |
nsp bind | 5 |
stabilizes proompa | 5 |
wobble position | 5 |
educational curriculum | 5 |
alkaline reduction | 5 |
vitro using | 5 |
translational initiation | 5 |
cell clusters | 5 |
significantly reduced | 5 |
among patients | 5 |
frameshift events | 5 |
rank sum | 5 |
recently identified | 5 |
edmonston strain | 5 |
nucleocapsid protein | 5 |
grubaughlab ct | 5 |
cd ra | 5 |
testing level | 5 |
hungry codons | 5 |
length infectious | 5 |
may serve | 5 |
fresh pbmc | 5 |
coding gap | 5 |
master mix | 5 |
sequence homology | 5 |
human neutralizing | 5 |
cellular processes | 5 |
early stage | 5 |
international travel | 5 |
allowed us | 5 |
translation continues | 5 |
cdna synthesis | 5 |
severe sars | 5 |
structural protein | 5 |
golgi function | 5 |
high monocytes | 5 |
transgenic mice | 5 |
protein translation | 5 |
control donors | 5 |
sybr green | 5 |
supervised umap | 5 |
sequence elements | 5 |
dna strand | 5 |
salt extract | 5 |
readthrough assay | 5 |
accession number | 5 |
terminal half | 5 |
false positives | 5 |
gene sets | 5 |
probable bat | 5 |
coronavirus nsp | 5 |
obtained using | 5 |
nonenveloped viruses | 5 |
fold change | 5 |
genomic sequence | 5 |
results presented | 5 |
like receptor | 5 |
initiator methionine | 5 |
data analysis | 5 |
proteins involved | 5 |
oxford nanopore | 5 |
highly expressed | 5 |
like protein | 5 |
much lower | 5 |
ts progeny | 5 |
key role | 5 |
mature mrna | 5 |
one catc | 5 |
anticoagulant activity | 5 |
clinical outcomes | 5 |
decreased sensitivity | 5 |
many years | 5 |
data bank | 5 |
cell marker | 5 |
expression plasmid | 5 |
ace receptor | 5 |
factor activity | 5 |
scientific community | 5 |
chain reaction | 5 |
lasker committee | 5 |
thrombotic complications | 5 |
viral life | 5 |
fusion gene | 5 |
testing criteria | 5 |
first three | 5 |
simultaneous slippage | 5 |
scientific establishment | 5 |
strand cdna | 5 |
containing mrnas | 5 |
kshv portal | 5 |
three different | 5 |
domestic travel | 5 |
antibodies used | 5 |
inflammatory responses | 5 |
minimal region | 5 |
circulating monocytes | 5 |
relatively high | 5 |
first position | 5 |
two sets | 5 |
system involvement | 5 |
localized classification | 5 |
mv genome | 5 |
cytometry analysis | 5 |
small glycopeptides | 5 |
highly similar | 5 |
cmv mp | 5 |
plate reader | 5 |
measured using | 5 |
fc fusion | 5 |
histocompatibility antigens | 5 |
lo cd | 5 |
fei tecnai | 5 |
clinical symptoms | 5 |
altered mental | 5 |
bars denote | 5 |
sequence alignment | 5 |
neutrophil compartment | 5 |
acceptor peptide | 5 |
also contribute | 5 |
hiring freezes | 5 |
late genes | 5 |
single polypeptide | 5 |
synthesized proteins | 5 |
genetic crossovers | 5 |
cell counts | 5 |
small vesicles | 5 |
codons recognized | 5 |
focused classification | 5 |
type cen | 5 |
across membranes | 5 |
unmodified uracil | 5 |
days later | 5 |
neutrophil count | 5 |
frame maintenance | 5 |
immune evasion | 5 |
reported covid | 5 |
rna polymerases | 5 |
replication cycle | 5 |
heparin lyases | 5 |
one might | 5 |
histocompatibility complex | 5 |
fresnel fringe | 5 |
cytokine production | 5 |
virus infected | 5 |
also showed | 5 |
reovirus cell | 5 |
charged residues | 5 |
proposed pseudoknot | 5 |
phase residual | 5 |
authors declare | 5 |
national institute | 5 |
stranded dna | 5 |
surface receptors | 5 |
reported cases | 5 |
ta binding | 5 |
first aug | 5 |
genomic data | 5 |
bound ace | 5 |
linked carbohydrate | 5 |
animal model | 5 |
blood donors | 5 |
i monoclonal | 5 |
cell cluster | 5 |
stem cell | 5 |
vp surface | 5 |
cellular hs | 5 |
validation cohort | 5 |
ha epitope | 5 |
structural studies | 5 |
membrane glycoproteins | 5 |
control experiments | 5 |
atomic resolution | 5 |
will allow | 5 |
endocytic pathway | 5 |
outbreak scenarios | 5 |
escherichia coli | 5 |
relion postprocess | 5 |
viral membrane | 5 |
competition binding | 5 |
dna viruses | 5 |
promoter sequences | 5 |
single base | 5 |
compare lanes | 5 |
linked sugars | 5 |
side chains | 5 |
viral leader | 5 |
reduced infection | 5 |
receptor recognition | 5 |
dimensional structures | 5 |
late promoters | 5 |
positive patients | 5 |
study will | 5 |
antibody cocktail | 5 |
molecular basis | 5 |
cell immunity | 5 |
golgi stacks | 5 |
outbreak associated | 5 |
mouse ace | 5 |
lung epithelial | 5 |
reporting rate | 5 |
dna translocation | 5 |
escherichia co | 5 |
single amino | 5 |
length sars | 5 |
dengue virus | 5 |
low availability | 5 |
virus neutralization | 5 |
overlapping reading | 5 |
control level | 5 |
rna sequences | 5 |
two adjacent | 5 |
tail length | 5 |
influenza viral | 5 |
cytokine storm | 5 |
protein kinase | 5 |
site mutations | 5 |
bacterial infection | 5 |
nm diameter | 5 |
per group | 5 |
suppressor cell | 5 |
sspe patients | 4 |
selective binding | 4 |
peptide fragments | 4 |
zombie uv | 4 |
splicing ratio | 4 |
viral lumen | 4 |
barre syndrome | 4 |
conditions used | 4 |
apical chamber | 4 |
rotavirus hemagglutinin | 4 |
infected host | 4 |
issues plaguing | 4 |
two patients | 4 |
cd cell | 4 |
containing two | 4 |
gene coding | 4 |
diversity among | 4 |
realistic outbreak | 4 |
free ribosomes | 4 |
nih ordinal | 4 |
urea buffer | 4 |
dna nanoball | 4 |
less severe | 4 |
increasing evidence | 4 |
kinetochore component | 4 |
microsomal vesicles | 4 |
yeast centromere | 4 |
recombinant protein | 4 |
cellular membrane | 4 |
case report | 4 |
hs st | 4 |
i fusion | 4 |
cells via | 4 |
mouse sperm | 4 |
extended abstracts | 4 |
state department | 4 |
healthcare workers | 4 |
least three | 4 |
expressed cd | 4 |
ribosomal subunit | 4 |
dmso stimulation | 4 |
uc san | 4 |
faceted health | 4 |
using high | 4 |
predict population | 4 |
transmission electron | 4 |
frame termination | 4 |
rough microsomes | 4 |
distal end | 4 |
novel human | 4 |
neutralizing monoclonal | 4 |
disseminated encephalomyelitis | 4 |
decreased electrophoretic | 4 |
time frame | 4 |
rna processing | 4 |
body encephalitis | 4 |
bd biosciences | 4 |
tubular interconnections | 4 |
conjugated anti | 4 |
fragment present | 4 |
translocated across | 4 |
bethesda research | 4 |
tract infection | 4 |
neurological abnormalities | 4 |
chromosome fragments | 4 |
vp inner | 4 |
two animal | 4 |
identified using | 4 |
ace adapted | 4 |
spring harbor | 4 |
binding affinity | 4 |
strong secondary | 4 |
acrosome reaction | 4 |
nlinked oligosaccharides | 4 |
splicing ratios | 4 |
previous experiments | 4 |
frame specific | 4 |
hs binding | 4 |
target cell | 4 |
length human | 4 |
medial cisternae | 4 |
catc density | 4 |
full occupancy | 4 |
specific human | 4 |
cell suspension | 4 |
peptide pools | 4 |
kd apparent | 4 |
several different | 4 |
bacterial expression | 4 |
patient sample | 4 |
found associated | 4 |
nonsense codon | 4 |
fold lower | 4 |
paramyxovirus sv | 4 |
sample preparation | 4 |
acute disseminated | 4 |
sialic acids | 4 |
many scientists | 4 |
isoelectric point | 4 |
specific activity | 4 |
dna sequences | 4 |
clinically proven | 4 |
trna slippage | 4 |
cellular ddrps | 4 |
codon readthrough | 4 |
review see | 4 |
small amount | 4 |
either side | 4 |
restriction endonuclease | 4 |
base pair | 4 |
qpcr analysis | 4 |
strong reduction | 4 |
antigen presentation | 4 |
online version | 4 |
selective pressure | 4 |
goat anti | 4 |
apparent size | 4 |
health status | 4 |
point mutations | 4 |
low dose | 4 |
also consistent | 4 |
rnaase treatment | 4 |
ii histocompatibility | 4 |
red dots | 4 |
containing mrna | 4 |
residues long | 4 |
cytokine levels | 4 |
time spent | 4 |
inflammatory monocytes | 4 |
hours later | 4 |
possible mechanisms | 4 |
protein structure | 4 |
gradient centrifugation | 4 |
dp oligosaccharides | 4 |
experiment shown | 4 |
possessing sperm | 4 |
porf subunits | 4 |
electron micrographs | 4 |
sv virion | 4 |
sperm motility | 4 |
virus spread | 4 |
capsid association | 4 |
viral clearance | 4 |
central role | 4 |
several cases | 4 |
site within | 4 |
helical motif | 4 |
tagged ctf | 4 |
ab initio | 4 |
near future | 4 |
mental health | 4 |
elution sample | 4 |
fold axis | 4 |
two mrnas | 4 |
single genetic | 4 |
promote frameshifting | 4 |
confidence interval | 4 |
persistent viruses | 4 |
infection may | 4 |
much less | 4 |
chain release | 4 |
dimensional reconstruction | 4 |
membrane gfp | 4 |
small molecules | 4 |
cell atlas | 4 |
plaque assay | 4 |
transfer rna | 4 |
transcription elongation | 4 |
culture cells | 4 |
entry depends | 4 |
patients exhibit | 4 |
physically distinct | 4 |
different viruses | 4 |
igg cr | 4 |
actin intron | 4 |
poster session | 4 |
inflammatory markers | 4 |
including add | 4 |
structurally distinct | 4 |
biological significance | 4 |
identified two | 4 |
therapeutic efficacy | 4 |
late messengers | 4 |
ciliated cell | 4 |
population behavior | 4 |
kinetochore protein | 4 |
nanopore technologies | 4 |
rna template | 4 |
exploring outbreak | 4 |
trif pathway | 4 |
sensitive mutation | 4 |
mature neutrophil | 4 |
occurs within | 4 |
rnaase tl | 4 |
acid substitutions | 4 |
rna sequence | 4 |
four times | 4 |
atomic models | 4 |
treated zonae | 4 |
vertex class | 4 |
endocytic vesicles | 4 |
vitro transcribed | 4 |
murine coronavirus | 4 |
mouse egg | 4 |
streaked onto | 4 |
stabilizing proompa | 4 |
base pairs | 4 |
raw data | 4 |
disease onset | 4 |
low neutrophils | 4 |
first discovered | 4 |
frameshift mutants | 4 |
response readiness | 4 |
glycosylated domain | 4 |
publicly available | 4 |
circulating cd | 4 |
i i | 4 |
mrna recognition | 4 |
membrane proximal | 4 |
retroviral gag | 4 |
differential expression | 4 |
specific mrnas | 4 |
experiments will | 4 |
small size | 4 |
region ii | 4 |
possess sperm | 4 |
reagent kit | 4 |
whether sars | 4 |
dmem supplemented | 4 |
patient group | 4 |
pbs containing | 4 |
human antibodies | 4 |
comprehensive educational | 4 |
initial design | 4 |
transmission dynamics | 4 |
detectable circulating | 4 |
global inhibition | 4 |
rna isolation | 4 |
ret rna | 4 |
daily covid | 4 |
strand synthesis | 4 |
tubular extensions | 4 |
heparin hs | 4 |
give rise | 4 |
alkaline phosphatase | 4 |
sendal virus | 4 |
fabp expression | 4 |
using spearman | 4 |
equal excellence | 4 |
special consideration | 4 |
lesser extent | 4 |
mutations affecting | 4 |
type strain | 4 |
le bert | 4 |
using cryosparc | 4 |
coronavirus rna | 4 |
atg codon | 4 |
frameshift suppression | 4 |
fold increase | 4 |
induced polypeptides | 4 |
eukaryotic cells | 4 |
nsp might | 4 |
capture study | 4 |
associated proteins | 4 |
cell biol | 4 |
prostate cancer | 4 |
activated cycling | 4 |
dimensional electrophoresis | 4 |
human respiratory | 4 |
peptides spanning | 4 |
particle classification | 4 |
scrnaseq data | 4 |
rabbit anti | 4 |
respiratory virus | 4 |
conserved sequence | 4 |
human brains | 4 |
dna content | 4 |
terminal phenotype | 4 |
electropositive surface | 4 |
ml hsase | 4 |
slippery run | 4 |
statistical significance | 4 |
community grubaughlab | 4 |
transfected cells | 4 |
open conformation | 4 |
missense mutagenesis | 4 |
viral components | 4 |
mrna encoding | 4 |
health score | 4 |
relatively low | 4 |
cd immature | 4 |
existing multiplayer | 4 |
bp upstream | 4 |
complex formed | 4 |
scrna sequencing | 4 |
type classification | 4 |
ge healthcare | 4 |
cognitive impairment | 4 |
virus strain | 4 |
infected cv | 4 |
glycol heparin | 4 |
inflammatory response | 4 |
neutralization activity | 4 |
pluripotent stem | 4 |
washed times | 4 |
kinetochore integrity | 4 |
cell suspensions | 4 |
cell compartment | 4 |
retroviral shift | 4 |
glycosylation deletions | 4 |
membrane lipids | 4 |
mannosidase i | 4 |
secondary cen | 4 |
red blood | 4 |
sequenase tm | 4 |
aaa aag | 4 |
mapping experiments | 4 |
stimulated gene | 4 |
later career | 4 |
experimental evidence | 4 |
chromosome cycle | 4 |
terminal region | 4 |
pol gene | 4 |
inclusion body | 4 |
sl rna | 4 |
discriminate patients | 4 |
vp assembly | 4 |
also involved | 4 |
heparin binding | 4 |
epithelial cell | 4 |
among different | 4 |
high titer | 4 |
cold spring | 4 |
recent evidence | 4 |
severe forms | 4 |
ncov spike | 4 |
molecular model | 4 |
studies using | 4 |
one reason | 4 |
synthetic transcripts | 4 |
concerted effort | 4 |
coated buds | 4 |
terminal amino | 4 |
zp following | 4 |
also revealed | 4 |
perm buffer | 4 |
cd ssc | 4 |
detailed methods | 4 |
connecticut state | 4 |
exchange chromatography | 4 |
displayed human | 4 |
low level | 4 |
positive control | 4 |
chronic neurological | 4 |
discrete shifts | 4 |
scientific conferences | 4 |
common lines | 4 |
hr incubation | 4 |
became resistant | 4 |
sspe cases | 4 |
phylogenetic analysis | 4 |
viral assembly | 4 |
cell morphology | 4 |
coronavirus infections | 4 |
protease digestion | 4 |
competing interests | 4 |
homozygous diploid | 4 |
el epitope | 4 |
likely due | 4 |
structural components | 4 |
patients will | 4 |
elution profiles | 4 |
also acts | 4 |
unique portal | 4 |
translational repression | 4 |
reporting rates | 4 |
significantly enriched | 4 |
protein product | 4 |
chromosome xiii | 4 |
two distinct | 4 |
empty vector | 4 |
diseased human | 4 |
two subtype | 4 |
single gene | 4 |
different cell | 4 |
peptide pool | 4 |
evaluate response | 4 |
critical role | 4 |
mutations introduced | 4 |
glycan shield | 4 |
two open | 4 |
monocytes among | 4 |
low titer | 4 |
online games | 4 |
dimeric nature | 4 |
unique reagents | 4 |
electrostatic potential | 4 |
also reduced | 4 |
learning capabilities | 4 |
encode proteins | 4 |
statistical comparisons | 4 |
new frame | 4 |
untranslated region | 4 |
transcribed using | 4 |
color flow | 4 |
polymerase complex | 4 |
fold axes | 4 |
resulting mrna | 4 |
i ifn | 4 |
previously demonstrated | 4 |
containing galactose | 4 |
proven protease | 4 |
facs buffer | 4 |
incoming viruses | 4 |
klenow fragment | 4 |
epitope prediction | 4 |
cell lysis | 4 |
ctf fusion | 4 |
better understand | 4 |
count data | 4 |
scenarios predict | 4 |
mm tcep | 4 |
blood monocytes | 4 |
three days | 4 |
virus matrix | 4 |
highly activated | 4 |
expression patterns | 4 |
human subjects | 4 |
cells also | 4 |
dysfunctional neutrophils | 4 |
checkpoint control | 4 |
cell targets | 4 |
mouse mammary | 4 |
probe containing | 4 |
dibutyl phthalate | 4 |
occurs via | 4 |
protein rbd | 4 |
surrounding capsid | 4 |
virtual pathogen | 4 |
biotek cytation | 4 |
nanoball sequencing | 4 |
event occurs | 4 |
bilobed structure | 4 |
similar results | 4 |
two structures | 4 |
monocytes within | 4 |
translation inhibition | 4 |
inflammatory conditions | 4 |
also contain | 4 |
initial interaction | 4 |
helper cells | 4 |
tobacco mosaic | 4 |
within total | 4 |
ace interaction | 4 |
systemic issues | 4 |
radial density | 4 |
one possibility | 4 |
tilt series | 4 |
test chromosome | 4 |
bayesian approach | 4 |
radiolabeling studies | 4 |
impaired type | 4 |
sample within | 4 |
modified form | 4 |
less infectious | 4 |
provide informed | 4 |
erythrocyte lysis | 4 |
also expressed | 4 |
particle reconstruction | 4 |
tegument protein | 4 |
mapping data | 4 |
premature stops | 4 |
neutralizing activity | 4 |
selective pressures | 4 |
must also | 4 |
cell analysis | 4 |
unless otherwise | 4 |
sensitive mutant | 4 |
white blood | 4 |
using stimulation | 4 |
secondary channel | 4 |
viral spike | 4 |
cell phenotype | 4 |
respiratory illness | 4 |
binding class | 4 |
human invariant | 4 |
virus produces | 4 |
cancer interventions | 4 |
results strongly | 4 |
circulating antibodies | 4 |
ribosomal subunits | 4 |
unusual mechanism | 4 |
specific manner | 4 |
england biolabs | 4 |
will help | 4 |
video sharing | 4 |
aminopentyl agarose | 4 |
proteins using | 4 |
protein synthesized | 4 |
particle cryo | 4 |
corresponding region | 4 |
among cd | 4 |
protein trimer | 4 |
symptomatic patients | 4 |
heterogeneous refinement | 4 |
linear regression | 4 |
simulated outbreaks | 4 |
viral particle | 4 |
catcs bound | 4 |
systemic inflammation | 4 |
protein bound | 4 |
hydrophobic amino | 4 |
virally infected | 4 |
conference abstracts | 4 |
great majority | 4 |
replication transcription | 4 |
two cohorts | 4 |
will likely | 4 |
background subtracted | 4 |
cytoplasmically exposed | 4 |
specifically recognized | 4 |
three sars | 4 |
elevated levels | 4 |
terminal portion | 4 |
even though | 4 |
natural variants | 4 |
translational frameshifting | 4 |
progeny virions | 4 |
narl site | 4 |
early endosomes | 4 |
first step | 4 |
suppress host | 4 |
cancer population | 4 |
raft pathways | 4 |
recently shown | 4 |
reassortant structures | 4 |
interferon activity | 4 |
defective interfering | 4 |
treated zp | 4 |
polyclonal antibodies | 4 |
relatively small | 4 |
shift sites | 4 |
reduced infectivity | 4 |
crispr cas | 4 |
surface proteins | 4 |
org community | 4 |
visualized using | 4 |
directed mutagenesis | 4 |
purified trigger | 4 |
small number | 4 |
cov infection | 4 |
rna derived | 4 |
measles inclusion | 4 |
washed three | 4 |
rare trna | 4 |
determined whether | 4 |
therapeutic strategies | 4 |
without affecting | 4 |
ctf gene | 4 |
mutant strains | 4 |
bacterial infections | 4 |
egg interaction | 4 |
right arm | 4 |
ox cd | 4 |
competent form | 4 |
human ifn | 4 |
high number | 4 |
induced marker | 4 |
oo simulations | 4 |
retroviral frameshift | 4 |
endocytic internalization | 4 |
responses directed | 4 |
among classical | 4 |
full sperm | 4 |
borohydride treatment | 4 |
terminal tail | 4 |
living cells | 4 |
several lines | 4 |
particle image | 4 |
specific size | 4 |
different hla | 4 |
evidence suggests | 4 |
spike rbd | 4 |
molecular weights | 4 |
experiments using | 4 |
fragment derived | 4 |
kindly provided | 4 |
increase engagement | 4 |
convalescent patients | 4 |
core domain | 4 |
docking protein | 4 |
frozen pbmc | 4 |
computer image | 4 |
direct fusion | 4 |
negatively charged | 4 |
convalescing covid | 4 |
immunoelectron microscopy | 4 |
rbd conformation | 4 |
titer group | 4 |
promega biotec | 4 |
proximal origin | 4 |
chronic inflammation | 4 |
total neutrophils | 4 |
reduced virion | 4 |
total cells | 4 |
viral glycoprotein | 4 |
molecular dynamics | 4 |
neutralizing human | 4 |
world health | 4 |
different regions | 4 |
structural element | 4 |
expressing cd | 4 |
giving rise | 4 |
capsid reconstruction | 4 |
recognition domains | 4 |
spliced viral | 4 |
spike mp | 4 |
systematic review | 4 |
fabp family | 4 |
virus assembly | 4 |
chloramphenicol acetyltransferase | 4 |
study provides | 4 |
may contribute | 4 |
immediately extracted | 4 |
also help | 4 |
kinetochore components | 4 |
rnp assembly | 4 |
first residues | 4 |
health organization | 4 |
mapping using | 4 |
tecnai spirit | 4 |
globular mass | 4 |
neutrophil subset | 4 |
symmetry imposed | 4 |
taken together | 4 |
current view | 4 |
viral transmission | 4 |
allelic variants | 4 |
nascent peptide | 4 |
transcription factors | 4 |
outer surface | 4 |
transfer agreement | 4 |
cancer treatments | 4 |
multiplayer online | 4 |
higher eukaryotes | 4 |
without symmetry | 4 |
viral sequences | 4 |
genetics system | 4 |
public video | 4 |
expressed high | 4 |
data demonstrate | 4 |
polymerase chain | 4 |
oral swab | 4 |
virus mrna | 4 |
frame fusion | 4 |
helpful discussions | 4 |
phase sars | 4 |
translocation channel | 4 |
golgi elements | 4 |
frameshift sequence | 4 |
complementary strand | 4 |
receptors involved | 4 |
rna genomes | 4 |
viral reads | 4 |
antibody domain | 4 |
statistical analysis | 4 |
inhibitory activity | 4 |
candidate covid | 4 |
aphthovirus genome | 4 |
control sample | 4 |
pandemic education | 4 |
large amounts | 4 |
recombinant rbd | 4 |
expression among | 4 |
endocytic mechanism | 4 |
sea urchin | 4 |
tyrosine kinases | 4 |
rbd mutants | 4 |
centromere dna | 4 |
defective measles | 4 |
human pluripotent | 4 |
anticodon interaction | 4 |
control measures | 4 |
cell staining | 4 |
deficient mice | 4 |
rna intermediate | 4 |
research laboratories | 4 |
low monocytes | 4 |
ordinal scale | 4 |
partially conserved | 3 |
curated particles | 3 |
mouse models | 3 |
viable spores | 3 |
northern italy | 3 |
good developability | 3 |
subsequently visualized | 3 |
plates followed | 3 |
knowledge gap | 3 |
aug initiation | 3 |
minor groove | 3 |
per pixel | 3 |
gene assay | 3 |
proteins required | 3 |
scale factor | 3 |
two molecules | 3 |
dna metabolism | 3 |
centromere function | 3 |
overlapping genes | 3 |
whether nsp | 3 |
coronavirus helicase | 3 |
expression strategies | 3 |
central nervous | 3 |
using biot | 3 |
ultrafast universal | 3 |
structural polypeptides | 3 |
unusual structure | 3 |
treated golgi | 3 |
proteins translated | 3 |
initio reconstruction | 3 |
sequencing reads | 3 |
like phenotype | 3 |
like hydrogen | 3 |
institutional biosafety | 3 |
infectious diseases | 3 |
mitotic recombination | 3 |
functionally replete | 3 |
exoplasmic domain | 3 |
cells specific | 3 |
intracellular parasites | 3 |
complete medium | 3 |
interests declaration | 3 |
frame codon | 3 |
smooth outer | 3 |
unknown whether | 3 |
protein chloramphenicol | 3 |
host mrnas | 3 |
structural organization | 3 |
coding rnas | 3 |
type membrane | 3 |
flanking sequence | 3 |
two cases | 3 |
also enriched | 3 |
protein docking | 3 |
pore size | 3 |
dsdna genome | 3 |
deep groove | 3 |
terminus domain | 3 |
uag readthrough | 3 |
intracellular cytokine | 3 |
vaccine design | 3 |
cell function | 3 |
angiotensin converting | 3 |
hamster lung | 3 |
also analyzed | 3 |
direct ex | 3 |
precursor protein | 3 |
acute viral | 3 |
clip turret | 3 |
genetic crossover | 3 |
rnase inhibitor | 3 |
bamhl sites | 3 |
red asterisk | 3 |
necrosis factor | 3 |
neuraminidase treatment | 3 |
immune epitope | 3 |
open question | 3 |
will take | 3 |
spread within | 3 |
complex immune | 3 |
synthesized membrane | 3 |
virus may | 3 |
total dose | 3 |
peak ill | 3 |
total response | 3 |
electron cryomicrographs | 3 |
permeabilization buffer | 3 |
membrane glycoprotein | 3 |
volcanoplot representation | 3 |
periportal triplexes | 3 |
subtype os | 3 |
primer sequences | 3 |
hours prior | 3 |
considered significant | 3 |
heterologous vp | 3 |
icosahedral capsid | 3 |
potential site | 3 |
virus infections | 3 |
vectors using | 3 |
limited evidence | 3 |
statistical tests | 3 |
multicenter study | 3 |
data also | 3 |
anti human | 3 |
occur within | 3 |
indicated amounts | 3 |
growth factor | 3 |
initiation codons | 3 |
bulk flow | 3 |
hunter reagent | 3 |
protease protection | 3 |
nucleotides beyond | 3 |
bac plasmids | 3 |
circulating sars | 3 |
free assays | 3 |
direct effect | 3 |
color assay | 3 |
cellular heparan | 3 |
trypanosome mrna | 3 |
nsp compared | 3 |
protein containing | 3 |
ionophore monensin | 3 |
single event | 3 |
causative agent | 3 |
times greater | 3 |
convalescent plasma | 3 |
clone map | 3 |
band migrating | 3 |
per disaccharide | 3 |
secreted protein | 3 |
cell binding | 3 |
following mild | 3 |
aaa aac | 3 |
mediated inhibition | 3 |
shorter poly | 3 |
gp i | 3 |
also bind | 3 |
gene using | 3 |
immune activation | 3 |
ty element | 3 |
specific amino | 3 |
sodium deoxycholate | 3 |
replacement site | 3 |
skewed toward | 3 |
may result | 3 |
feline leukemia | 3 |
column containing | 3 |
contains methionine | 3 |
using flojo | 3 |
genes encoding | 3 |
layer chromatography | 3 |
ifn levels | 3 |
computed using | 3 |
testing positive | 3 |
alternative model | 3 |
codon intervals | 3 |
flojo analysis | 3 |
fold higher | 3 |
incorporation ratios | 3 |
lymphocytic choriomeningitis | 3 |
measured hours | 3 |
prophylactic efficacy | 3 |
trans side | 3 |
systemic immune | 3 |
early epidemic | 3 |
sucrose cushion | 3 |
inhibited sperm | 3 |
universities might | 3 |
largest rna | 3 |
pellucida glycoprotein | 3 |
sites within | 3 |
larger molecular | 3 |
infected immune | 3 |
double frameshift | 3 |
portal channel | 3 |
patient neutrophils | 3 |
small molecule | 3 |
cx cl | 3 |
alanine trna | 3 |
blue color | 3 |
apical side | 3 |
mer peptides | 3 |
dalgarno sequence | 3 |
least two | 3 |
exploratory research | 3 |
input sample | 3 |
references therein | 3 |
viral mutations | 3 |
specific mutagenesis | 3 |
medical research | 3 |
glycoprotein el | 3 |
nontemplated nucleotides | 3 |
will require | 3 |
igg antibodies | 3 |
including il | 3 |
independent transformants | 3 |
antiviral immunity | 3 |
motion correction | 3 |
five classes | 3 |
protein complexes | 3 |
johns hopkins | 3 |
uag stop | 3 |
consensus genomes | 3 |
revealed two | 3 |
pooled controls | 3 |
local search | 3 |
superscript iii | 3 |
virological assessment | 3 |
changes induced | 3 |
antibody igg | 3 |
diploid strain | 3 |
large numbers | 3 |
brain rna | 3 |
calprotectin levels | 3 |
airway epithelia | 3 |
also suggest | 3 |
plant viral | 3 |
alveolar type | 3 |
heterozygous diploid | 3 |
brain infections | 3 |
efficient ribosomal | 3 |
autopsy studies | 3 |
virus growth | 3 |
experimental conditions | 3 |
labeled material | 3 |
reference genome | 3 |
media containing | 3 |
edman degradation | 3 |
along microtubules | 3 |
pol fusion | 3 |
airway epithelium | 3 |
kshv cells | 3 |
partially spliced | 3 |
peptide sequence | 3 |
expression system | 3 |
using vaccinia | 3 |
decreased expression | 3 |
internal modification | 3 |
cell memory | 3 |
antibodies raised | 3 |
activation induced | 3 |
viral titration | 3 |
vitro synthesized | 3 |
expressed nsp | 3 |
subgenomic rna | 3 |
yeast strains | 3 |
hairpin loop | 3 |
coli plasma | 3 |
elution samples | 3 |
will result | 3 |
incident cases | 3 |
fusion inhibition | 3 |
circulating levels | 3 |
neutrophil precursors | 3 |
transmissible gastroenteritis | 3 |
provide evidence | 3 |
dependent manner | 3 |
infection peak | 3 |
southern new | 3 |
also identified | 3 |
activated neutrophils | 3 |
one type | 3 |
may drive | 3 |
artic network | 3 |
protein component | 3 |
nsp protein | 3 |
chinese center | 3 |
cell transfer | 3 |
size heterogeneity | 3 |
protein recognition | 3 |
recombinant sars | 3 |
kinetoplastid mitochondrial | 3 |
following either | 3 |
human liver | 3 |
slippery sequences | 3 |
primer extended | 3 |
infectious kshv | 3 |
discovery rate | 3 |
dmso control | 3 |
suppressor trna | 3 |
key resource | 3 |
translation reactions | 3 |
homopolymeric stretches | 3 |
protein sigma | 3 |
procapsid formation | 3 |
spherical mask | 3 |
nlrp inflammasome | 3 |
kshv porf | 3 |
covid world | 3 |
drastically reduced | 3 |
patients showed | 3 |
humidified atmosphere | 3 |
take place | 3 |
late stage | 3 |
small neutral | 3 |
short sequence | 3 |
secondary screen | 3 |
active center | 3 |
vitro protein | 3 |
murine mastocytoma | 3 |
sv genomic | 3 |
cellular adhesion | 3 |
ic values | 3 |
results show | 3 |
nearly wild | 3 |
given window | 3 |
different glycoproteins | 3 |
cov neutralization | 3 |
events occur | 3 |
independent samples | 3 |
assays using | 3 |
virtual poster | 3 |
human parainfluenza | 3 |
primers used | 3 |
academic conferences | 3 |
states will | 3 |
ongoing covid | 3 |
soluble proteins | 3 |
noncoding strand | 3 |
three major | 3 |
xbal linkers | 3 |
fragment coding | 3 |
novel therapeutic | 3 |
full catc | 3 |
discontinuous mappings | 3 |
membranespanning segment | 3 |
rna pseudoknot | 3 |
trypanosoma brucei | 3 |
serum albumin | 3 |
visualization system | 3 |
exhibit increased | 3 |
structural changes | 3 |
genomic positions | 3 |
cells may | 3 |
additional sequences | 3 |
sugar alcohols | 3 |
variable gene | 3 |
detailed information | 3 |
pellucidae incubated | 3 |
volume fractions | 3 |
os parent | 3 |
moderate cases | 3 |
pandemic control | 3 |
early phase | 3 |
infected monolayer | 3 |
peptide chain | 3 |
scored negative | 3 |
synthetic oligonucleotides | 3 |
borohydride eluted | 3 |
scientific talks | 3 |
natural selection | 3 |
epitope mapping | 3 |
cytokine release | 3 |
particles using | 3 |
cell sequencing | 3 |
cell assay | 3 |
via activation | 3 |
small animal | 3 |
disease course | 3 |
rna phage | 3 |
mitochondrial transcripts | 3 |
replicase gene | 3 |
viral spread | 3 |
mrna kit | 3 |
various viral | 3 |
cell help | 3 |
barcoded rna | 3 |
hamster sera | 3 |
ten dam | 3 |
five expanded | 3 |
intracellular compartment | 3 |
several variants | 3 |
virus introductions | 3 |
two strands | 3 |
cov rbd | 3 |
site cleft | 3 |
transcripts initiated | 3 |
six leucine | 3 |
flow cytometer | 3 |
unexposed healthy | 3 |
activity levels | 3 |
cancer outcomes | 3 |
protein modification | 3 |
results confirm | 3 |
may lead | 3 |
anticoagulant heparin | 3 |
travel data | 3 |
envelope proteins | 3 |
specific rna | 3 |
chromosome fragmentation | 3 |
pbmc dataset | 3 |
umap visualization | 3 |
volume material | 3 |
encoding region | 3 |
peripheral immune | 3 |
functional significance | 3 |
cellular genes | 3 |
expansion segment | 3 |
extracts prepared | 3 |
viral genes | 3 |
per day | 3 |
variants including | 3 |
concomitant immune | 3 |
frameshifting seen | 3 |
posttranslational processing | 3 |
uncoating program | 3 |
glycoproteins gc | 3 |
initial attempts | 3 |
generate new | 3 |
water bath | 3 |
plus medium | 3 |
include structural | 3 |
stably expressing | 3 |
protein pseudotyped | 3 |
natural infection | 3 |
expanded orientations | 3 |
unspliced ratio | 3 |
budded cells | 3 |
virological synapses | 3 |
homology model | 3 |
mutant rnas | 3 |
gene function | 3 |
term neurological | 3 |
fold changes | 3 |
several studies | 3 |
coated vesicle | 3 |
tissue tropism | 3 |
also includes | 3 |
short helix | 3 |
way anova | 3 |
advisory board | 3 |
may represent | 3 |
glycoprotein structural | 3 |